Publications by authors named "Kou Kimoto"

Claim this Profile
H
High feasibility of salivary therapeutic drug monitoring in linezolid, but lower feasibility in tedizolid: a single-dose study in healthy subjects and a monocentric prospective exploratory study in patients who received linezolid.
Hitoshi Kawasuji, Yasuhiro Tsuji, Keiko Miyaki, Takahiko Aoyama, Fumihiro Kurosaki, Kou Kimoto

J Antimicrob Chemother· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful 30-Day Nirmatrelvir/Ritonavir Treatment of a Patient Who Developed Multi-relapsed COVID-19 After Receiving R-CHOP Against Follicular Lymphoma.
Kou Kimoto, Hitoshi Kawasuji, Yoshihiro Yoshida, Hiroshi Yamada, Shunsuke Yazawa

Cureus· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between sore throat and early immune responses against COVID-19 before and after the emergence of the Omicron variant.
Yusuke Takegoshi, Kentaro Nagaoka, Toshiki Kido, Hitoshi Kawasuji, Yushi Murai, Kou Kimoto

Ann Transl Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low pre-infection levels of neutralizing antibody in breakthrough infections after bivalent BA.4-5 vaccine and practical application of dried blood spots.
Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Hiroshi Yamada, Yoshihiro Yoshida, Kou Kimoto

Vaccine· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection.
Hitoshi Kawasuji, Yoshitomo Morinaga, Kentaro Nagaoka, Hideki Tani, Yoshihiro Yoshida, Kou Kimoto

Front Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Incidence of Metastatic Infections in Panton-Valentine Leucocidin-Negative, Community-Acquired Methicillin-Resistant Bacteremia: An 11-Year Retrospective Study in Japan.
Hitoshi Kawasuji, Yoshihiro Ikezawa, Mika Morita, Kazushige Sugie, Mayu Somekawa, Kou Kimoto

Antibiotics (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dominant CT Patterns and Immune Responses during the Early Infection Phases of Different SARS-CoV-2 Variants.
Kentaro Nagaoka, Hitoshi Kawasuji, Yusuke Takegoshi, Yushi Murai, Makito Kaneda, Kou Kimoto

Viruses· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Linezolid Versus Vancomycin, Teicoplanin, or Daptomycin against Methicillin-Resistant Bacteremia: A Systematic Review and Meta-Analysis.
Hitoshi Kawasuji, Kentaro Nagaoka, Yasuhiro Tsuji, Kou Kimoto, Yusuke Takegoshi

Antibiotics (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Study of Three Commercial Blood (1→3)-β-D-glucan Detection Reagents for Invasive Mycosis.
Yuki Miyajima, Kentaro Nagaoka, Yusuke Takegoshi, Makito Kaneda, Yushi Murai, Kou Kimoto

Med Mycol J· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5.
Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Yumiko Saga, Hiroshi Yamada, Kou Kimoto

Microbiol Spectr· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19.
Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Yoshihiro Yoshida, Yusuke Takegoshi, Kou Kimoto

J Med Virol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed neutralizing antibody response in the acute phase correlates with severe progression of COVID-19.
Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Miyuki Kimura, Hiroshi Yamada, Kou Kimoto

Sci Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of nasopharyngeal viral load at discharge in patients with COVID-19.
Yasutaka Fukui, Hitoshi Kawasuji, Yusuke Taekgoshi, Makito Kaneda, Yushi Murai, Kou Kimoto

J Infect Chemother· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of COVID-19 diagnosed with favipiravir-induced drug fever based on a positive drug-induced lymphocyte stimulation test.
Yushi Murai, Hitoshi Kawasuji, Yusuke Takegoshi, Makito Kaneda, Kou Kimoto

Int J Infect Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients.
Hitoshi Kawasuji, Yasuhiro Tsuji, Chika Ogami, Makito Kaneda, Yushi Murai, Kou Kimoto

Antibiotics (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients.
Hitoshi Kawasuji, Yasuhiro Tsuji, Chika Ogami, Kou Kimoto, Akitoshi Ueno

BMC Pharmacol Toxicol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis